Research

Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis

Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature

Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

Brain and lung imaging correlation in patients with COVID-19: could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? a global multicenter observational Study

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

Vaccinations in multiple sclerosis patients receiving disease-modifying drugs

Is the Frontal Lobe the Primary Target of SARS-CoV-2 ?

Acute ischemic stroke in patients with COVID-19: an analysis from Get With The Guidelines-Stroke

Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study

Brainstem clinical and neurophysiological involvement in COVID-19

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication